Maximizing the Value and Impact of Your Suicide/Depression Screening Program
Suicide is a preventable public health problem and yet it remains a leading, and increasing cause of death in the United States. Every day roughly 132 Americans die by suicide, or 48,000 individuals every year representing 950,000 years of potential life lost and a cost of $69 billion in combined work-loss and medical costs. Increasingly, hospitals are finding themselves on the front line of this epidemic as they seek to care for those who have attempted, or who endorse suicide.
In an effort to bolster how organizations identify and respond to suicidal patients beginning July 1, 2019 seven new and revised elements of performance are applicable to all Joint Commission accredited hospitals and behavioral health organizations. These new requirements are designed to improve the quality and safety of care for those being treated for behavioral health conditions and those who are identified as high risk for suicide. The work effort required to achieve compliance should not be underestimated, but neither should the opportunities that emerge from this important work. This webinar is intended to explore implementation and follow on strategies intended to maximize the value and impact of your organization’s suicide/depression screening program.
Webinar attendees will be able to:
- Recall the seven revised Joint Commission elements of performance
- Recognize the need for innovation as these requirements are applied in different environments
- Discuss the pros and cons of the different validated screening and assessment tools
- Describe the results of targeted versus comprehensive screening programs
- Explain the potential synergy in engaging and communicating patient primary care providers
- Describe the opportunity to engage with your community
- Discuss the need for measures to track the reliability and impact of your program
Date and Time
Thursday, October 22, 2020 from 10:00am-11:00am Pacific
Click hereto register for this webinar.
Dr. Billman completed a combined Bachelors/Masters program of study at Stanford University in 1979, and received an M.D. degree from the University of California at San Diego in 1983. His postgraduate training in Anatomic and Clinical Pathology was also received at UCSD In 1986,He joined the pathology faculty at Rady Children’s Hospital in San Diego where he held the position of Associate Director of Pathology for 14 years. In 2000, he applied for, was accepted as a fellow in Outcomes research at Rady Children’s Hospital’s Center For Child Health Outcomes. In 2001, after the completion of this fellowship, he served as Rady Children’s Hospital’s first Medical Safety Officer. In 2004 – He became the Director of Patient Safety at Children’s Hospitals and Clinics of Minnesota. In 2009, he returned to Rady Children’s Hospital in 2009 where it is now my privilege to serve as their Chief Quality Officer. In this position, he is responsible for both strategic and operational activities which include:
- Identifying and implementing initiatives aimed at improving patient care quality.
- Leading continuous improvement programs throughout the organization
- Taking a clinical leadership role in evaluating and promoting reliable care delivery
- Strengthening data and information capabilities of the organization and championing a data driven environment
- Collaborating with executives, leaders and Clinicians.
- Most Unusual Hobby: High Altitude Model Rocketry
- Proudest Accomplishment: Two wonderful, talented, and kind adult children: Matt & Becky.
Continuing Education Credit
One complimentary CE unit will be provided to dues-paying member hospitals of the Hospital Quality Institute, CHPSO Patient Safety Organization, the California Hospital Association or the regional hospital associations in CA.
HQI is an approved continuing education (CE) provider by the California Board of Registered Nursing and will provide CHPSO members an opportunity to earn CEs. Provider Number CEP16793 for 1.0 contact hour.
HQI does not currently offer ACPE approved Pharmacy CE, but the State of California will accept CE from courses which have been approved for continuing education by the Medical Board of California, the California Board of Podiatric Medicine, the California Board of Registered Nursing or the Dental Board of California towards their California continuing education requirement (Section 1732.2(b) of the California Code of Regulations). Pharmacists need to keep track of CE from these sources on their own as they are not submitted to NAPB.